Forward Citations = 2,822

Loading Chart...

3 inventors (with patents filed for the assignee):

Marvin J Slepian (16 out of 41 patents)

Anton E Schindler (7 out of 9 patents)

Stephen P Massia (5 out of 5 patents)

16 patents: Sort by Forward Citations

1. 6802811 - Sensing, interrogating, storing, telemetering and responding medical implants (2004-10-12),

2. 6699272 - Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein (2004-03-02),

3. 6443941 - Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein (2002-09-03),

4. 6290729 - Local polymeric gel cellular therapy (2001-09-18),

5. 6287320 - Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens (2001-09-11),

6. 6071956 - Treatment of tissues to reduce subsequent response to injury (2000-06-06),

7. 5947977 - Apparatus and polymeric endoluminal sealing (1999-09-07),

8. 5914345 - Treatment of tissues to reduce subsequent response to injury (1999-06-22),

9. 5843156 - Local polymeric gel cellular therapy (1998-12-01),

10. 5800538 - Biodegradable polymeric endoluminal sealing process (1998-09-01),

11. 5749922 - Biodegradable polymeric endoluminal sealing process, apparatus and (1998-05-12),

12. 5674287 - Biodegradable polymeric endoluminal sealing process, apparatus and (1997-10-07),

13. 5662609 - Method and apparatus for treatment of focal disease in hollow tubular (1997-09-02),

14. 5575815 - Local polymeric gel therapy (1996-11-19),

15. 5328471 - Method and apparatus for treatment of focal disease in hollow tubular (1994-07-12),

Company Overview

Endoluminal Therapeutics, Inc. is a medical technology company based in Tucson, Arizona, specializing in the development of innovative therapeutic solutions for gastrointestinal diseases. The company focuses on creating advanced endoluminal devices that aim to improve patient outcomes through minimally invasive procedures. By leveraging cutting-edge research and technology, Endoluminal Therapeutics is dedicated to addressing unmet medical needs in the field of digestive health, enhancing the quality of care for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#39 in Tucson, AZ

#237 in Arizona

#19,922 in US

#37,831 in the World

Tucson, AZ, United States of America

Endoluminal Therapeutics, Inc.

Forward Citations = 2,822

3 inventors:

Marvin J Slepian (16 out of 41 patents)

Anton E Schindler (7 out of 9 patents)

Stephen P Massia (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endoluminal Therapeutics, Inc.. Retrieved from https://idiyas.com/company/endoluminal-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]